Journal of Veterinary Science

The Korean Society of Veterinary Science (대한수의학회)
권호 표지
DOI QR코드

DOI QR Code

Serum homocysteine concentration in dogs with immunosuppressant-responsive enteropathy

  • Received : 2019.08.06
  • Accepted : 2020.03.27
  • Published : 2020.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Homocysteine (HCY) was evaluated in healthy and chronic enteropathic dogs, however no studies on dogs with immunosuppressant-responsive enteropathy are available. Objectives: The aim was to evaluate serum HCY concentrations and its prognostic role in dogs with immunosuppressant-responsive enteropathy compared to healthy dogs. Methods: Serum HCY concentration was statistically compared between 24 healthy dogs and 29 dogs with immunosuppressant-responsive enteropathy. Correlation analyses between serum total protein, albumin (ALB), C-reactive protein (CRP), folate and cobalamin, and serum HCY concentration were performed in immunosuppressant-responsive enteropathic dogs. Results: The associations between serum HCY concentration and clinical, histological, endoscopic scores and follow-up were evaluated. Mean serum HCY concentration was higher in immunosuppressant-responsive enteropathic dogs compared to control dogs (30.22 ± 8.67 µmol/L vs. 5.26 ± 2.78 µmol/L; p < 0.0001). No association between serum HCY concentration and total protein, ALB, CRP, folate concentration as well as, clinical score, histological and endoscopic scores was found. A negative correlation between serum HCY concentration and cobalamin was noted (p = 0.0025, r = -0.54). No significant difference in HCY was found between responsive and non-responsive dogs or between survivors and non-survivors. Conclusions: Although, serum HCY concentration was higher in immunosuppressant-responsive enteropathy, its prognostic value remains unclear. However, further prospective, large-scale studies are warranted to better investigate the possible prognostic role of HCY in immunosuppressant-responsive enteropathic dogs.

Keywords

Acknowledgement

We would like to thank Pietro Ruggiero and Giuseppe De Cata for their contribution to this paper.

References

  1. Kather S, Grutzner N, Kook PH, Dengler F, Heilmann RM. Review of cobalamin status and disorders of cobalamin metabolism in dogs. J Vet Intern Med. 2020;34(1):13-28. https://doi.org/10.1111/jvim.15638
  2. Golynski M, Lutnicki K, Krumrych W, Szczepanik M, Golynska M, Wilkolek P, Adamek L, Sitkowski L, Kurek L. Relationship between total homocysteine, folic acid, and thyroid hormones in hypothyroid dogs. J Vet Intern Med. 2017;31(5):1403-1405. https://doi.org/10.1111/jvim.14804
  3. Zhu S, Li J, Bing Y, Yan W, Zhu Y, Xia B, Chen M. Diet-induced hyperhomocysteinaemia increases intestinal inflammation in an animal model of colitis. J Crohns Colitis. 2015;9(9):708-719. https://doi.org/10.1093/ecco-jcc/jjv094
  4. Harrington DJ. Laboratory assessment of vitamin B12 status. J Clin Pathol. 2017;70(2):168-173. https://doi.org/10.1136/jclinpath-2015-203502
  5. Berghoff N, Suchodolski JS, Steiner JM. Serum homocysteine concentrations in dogs with chronic enteropathies. J Vet Intern Med. 2013;27:699-700.
  6. Lippi G, Plebani M. Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here? Clin Chem Lab Med. 2012;50(12):2075-2080. https://doi.org/10.1515/cclm-2012-0372
  7. Joseph J, Loscalzo J. Methoxistasis: integrating the roles of homocysteine and folic acid in cardiovascular pathobiology. Nutrients. 2013;5(8):3235-3256. https://doi.org/10.3390/nu5083235
  8. Saibeni S, Cattaneo M, Vecchi M, Zighetti ML, Lecchi A, Lombardi R, Meucci G, Spina L, de Franchis R. Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol. 2003;98(1):112-117. https://doi.org/10.1016/S0002-9270(02)05828-8
  9. Oussalah A, Gueant JL, Peyrin-Biroulet L. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther. 2011;34(10):1173-1184. https://doi.org/10.1111/j.1365-2036.2011.04864.x
  10. Rossi S, Rossi G, Giordano A, Paltrinieri S. Homocysteine measurement by an enzymatic method and potential role of homocysteine as a biomarker in dogs. J Vet Diagn Invest. 2008;20(5):644-649. https://doi.org/10.1177/104063870802000520
  11. Grutzner N, Heilmann RM, Stupka KC, Rangachari VR, Weber K, Holzenburg A, Suchodolski JS, Steiner JM. Serum homocysteine and methylmalonic acid concentrations in Chinese Shar-Pei dogs with cobalamin deficiency. Vet J. 2013;197(2):420-426. https://doi.org/10.1016/j.tvjl.2013.02.002
  12. Rossi G, Breda S, Giordano A, Pengo G, Dall'Ara P, Rossi G, Bo S, Paltrinieri S. Association between hypocobalaminaemia and hyperhomocysteinaemia in dogs. Vet Rec. 2013;172(14):365.
  13. Heilmann RM, Grutzner N, Iazbik MC, Lopes R, Bridges CS, Suchodolski JS, Couto CG, Steiner JM. Hyperhomocysteinemia in Greyhounds and its association with hypofolatemia and other clinicopathologic variables. J Vet Intern Med. 2017;31(1):109-116. https://doi.org/10.1111/jvim.14597
  14. Cayir C, Kozat S. Investigation of Homocysteine levels in healthy dogs. JVSAH. 2016;4:305.
  15. Dandrieux JR. Inflammatory bowel disease versus chronic enteropathy in dogs: are they one and the same? J Small Anim Pract. 2016;57(11):589-599. https://doi.org/10.1111/jsap.12588
  16. Nakashima K, Hiyoshi S, Ohno K, Uchida K, Goto-Koshino Y, Maeda S, Mizutani N, Takeuchi A, Tsujimoto H. Prognostic factors in dogs with protein-losing enteropathy. Vet J. 2015;205(1):28-32. https://doi.org/10.1016/j.tvjl.2015.05.001
  17. Allenspach K, Wieland B, Grone A, Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med. 2007;21(4):700-708. https://doi.org/10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2
  18. Toresson L, Steiner JM, Spodsberg E, Olmedal G, Suchodolski JS, Lidbury JA, Spillmann T. Effects of oral versus parenteral cobalamin supplementation on methylmalonic acid and homocysteine concentrations in dogs with chronic enteropathies and low cobalamin concentrations. Vet J. 2019;243:8-14. https://doi.org/10.1016/j.tvjl.2018.11.004
  19. Jergens AE, Schreiner CA, Frank DE, Niyo Y, Ahrens FE, Eckersall PD, Benson TJ, Evans R. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med. 2003;17(3):291-297. https://doi.org/10.1111/j.1939-1676.2003.tb02450.x
  20. Simpson KW. Managing chronic enteropathies in dogs Part 1 and 2. Pacific Veterinary Conference 2017; June 29, 2017 - July 2, 2017; Long Beach, CA, USA. Sacramento: California Veterinary Medical Association; 2017, 10-17.
  21. Washabau RJ, Day MJ, Willard MD, Hall EJ, Jergens AE, Mansell J, Minami T, Bilzer TW; WSAVA International Gastrointestinal Standardization Group. Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. J Vet Intern Med. 2010;24(1):10-26. https://doi.org/10.1111/j.1939-1676.2009.0443.x
  22. Allenspach KA, Mochel JP, Du Y, Priestnall SL, Moore F, Slayter M, Rodrigues A, Ackermann M, Krockenberger M, Mansell J. Correlating gastrointestinal histopathologic changes to clinical disease activity in dogs with idiopathic inflammatory bowel disease. Vet Pathol. 2019;56:435-443. https://doi.org/10.1177/0300985818813090
  23. Moser K, Mitze S, Teske E, von Bomhard W, Stockhaus C. Correlation of clinical, diagnostic and histopathological parameters in dogs with chronic lymphocytic-plasmacytic enteropathy. Tierarztl Prax Ausg K Klientiere Heimtiere. 2018;46(1):15-20. https://doi.org/10.15654/TPK-170445
  24. Day MJ, Bilzer T, Mansell J, Wilcock B, Hall EJ, Jergens A, Minami T, Willard M, Washabau R; World Small Animal Veterinary Association Gastrointestinal Standardization Group. Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group. J Comp Pathol. 2008;138 Suppl 1:S1-S43. https://doi.org/10.1016/j.jcpa.2008.01.001
  25. Slovak JE, Wang C, Sun Y, Otoni C, Morrison J, Deitz K, LeVine D, Jergens AE. Development and validation of an endoscopic activity score for canine inflammatory bowel disease. Vet J. 2015;203(3):290-295. https://doi.org/10.1016/j.tvjl.2014.12.030
  26. Grutzner N, Suchodolski JS, Steiner JM. Relationship between cobalamin-dependent metabolites and both serum albumin and alpha1-proteinase inhibitor concentrations in hypocobalaminemic dogs of 7 different breeds. Vet Clin Pathol. 2014;43(4):561-566. https://doi.org/10.1111/vcp.12204
  27. Weisshof R, Chermesh I. Micronutrient deficiencies in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2015;18(6):576-581. https://doi.org/10.1097/MCO.0000000000000226
  28. Koutroubakis IE, Malliaraki N, Dimoulios PD, Karmiris K, Castanas E, Kouroumalis EA. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci. 2004;49(9):1433-1437. https://doi.org/10.1023/B:DDAS.0000042242.22898.d9
  29. Mansoor MA, Bergmark C, Svardal AM, Lonning PE, Ueland PM. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease. Arterioscler Thromb Vasc Biol. 1995;15(2):232-240. https://doi.org/10.1161/01.ATV.15.2.232
  30. Solem CA, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(8):707-712. https://doi.org/10.1097/01.MIB.0000173271.18319.53
  31. Otoni CC, Heilmann RM, Garcia-Sancho M, Sainz A, Ackermann MR, Suchodolski JS, Steiner JM, Jergens AE. Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease. J Vet Intern Med. 2018;32(3):999-1008. https://doi.org/10.1111/jvim.15123
  32. Finch JM, Joseph J. Homocysteine, cardiovascular inflammation, and myocardial remodeling. Cardiovasc Hematol Disord Drug Targets. 2010;10(4):241-245. https://doi.org/10.2174/187152910793743887
  33. Nilsson K, Gustafson L, Hultberg B. Elevated plasma homocysteine level in vascular dementia reflects the vascular disease process. Dement Geriatr Cogn Dis Extra. 2013;3(1):16-24. https://doi.org/10.1159/000345981
  34. Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, Lovecchio M, Gasbarrini G, Cittadini A, Gasbarrini A. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol. 2005;100(4):886-895. https://doi.org/10.1111/j.1572-0241.2005.41469.x
  35. Twig G, Zandman-Goddard G, Szyper-Kravitz M, Shoenfeld Y. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications. Ann N Y Acad Sci. 2005;1051(1):166-173. https://doi.org/10.1196/annals.1361.058
  36. Goodwin LV, Goggs R, Chan DL, Allenspach K. Hypercoagulability in dogs with protein-losing enteropathy. J Vet Intern Med. 2011;25(2):273-277. https://doi.org/10.1111/j.1939-1676.2011.0683.x
  37. Lee CM, Jeong DM, Kang MH, Kim SG, Han JI, Park HM. Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs. Am J Vet Res. 2017;78(4):440-446. https://doi.org/10.2460/ajvr.78.4.440